Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Halozyme TherapeuticsKodiak SciencesTwist BioscienceVir BiotechnologyAdaptive Biotechnologies
SymbolNASDAQ:HALONASDAQ:KODNASDAQ:TWSTNASDAQ:VIRNASDAQ:ADPT
Price Information
Current Price$48.84$117.48$133.84$47.95$42.16
52 Week RangeBuyHoldHoldHoldBuy
MarketRank™
Overall Score1.51.31.21.71.6
Analysis Score1.52.11.24.23.3
Community Score2.71.82.52.52.4
Dividend Score0.00.00.00.00.0
Ownership Score1.72.51.71.71.7
Earnings & Valuation Score1.90.00.60.00.6
Analyst Ratings
Consensus RecommendationBuyHoldHoldHoldBuy
Consensus Price Target$42.92$128.64$137.50$66.00$61.40
% Upside from Price Target-12.13% downside9.50% upside2.73% upside37.64% upside45.64% upside
Trade Information
Market Cap$7.00 billion$6.01 billion$6.51 billion$6.14 billion$5.87 billion
Beta1.771.420.83-0.990.35
Average Volume1,383,070303,541972,2231,729,5511,001,723
Sales & Book Value
Annual Revenue$195.99 millionN/A$90.10 million$8.09 million$85.07 million
Price / Sales35.71N/A72.26758.5869.00
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.63 per share$9.32 per share$7.53 per share$3.87 per share$4.59 per share
Price / Book77.52N/A17.7712.399.19
Profitability
Net Income$-72,240,000.00$-47,370,000.00$-139,930,000.00$-174,680,000.00$-68,610,000.00
EPS($0.50)($1.25)($3.00)($5.76)($1.01)
Trailing P/E Ratio305.25N/AN/AN/AN/A
Forward P/E Ratio31.92N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins10.78%N/A-155.31%-339.61%-132.32%
Return on Equity (ROE)24.29%-32.32%-44.62%-47.11%-20.15%
Return on Assets (ROA)4.08%-23.86%-35.49%-39.44%-13.09%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio3.98%N/AN/AN/AN/A
Current Ratio18.49%16.96%9.29%11.03%8.70%
Quick Ratio16.36%16.96%8.95%11.03%8.59%
Ownership Information
Institutional Ownership Percentage98.45%82.29%87.90%54.49%80.80%
Insider Ownership Percentage2.60%39.30%7.00%37.20%22.20%
Miscellaneous
Employees13672525327622
Shares Outstanding143.30 million51.16 million48.65 million127.99 million139.22 million
Next Earnings Date5/10/2021 (Confirmed)5/10/2021 (Estimated)5/6/2021 (Estimated)5/11/2021 (Estimated)5/5/2021 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable
SourceHeadline
Oregon Adaptive Sports elects new board presidentOregon Adaptive Sports elects new board president
ktvz.com - April 22 at 2:46 AM
Adaptive Learning Market Research Report, Demand, Industry Analysis, Share, Growth, Applications, Types and Forecasts Report 2028Adaptive Learning Market Research Report, Demand, Industry Analysis, Share, Growth, Applications, Types and Forecasts Report 2028
sbwire.com - April 20 at 5:44 PM
Interesting ADPT Put And Call Options For June 18thInteresting ADPT Put And Call Options For June 18th
nasdaq.com - April 20 at 12:44 PM
Fixed-Point Maximum Total Complex Correntropy Algorithm for Adaptive FilterFixed-Point Maximum Total Complex Correntropy Algorithm for Adaptive Filter
ieeexplore.ieee.org - April 19 at 10:16 AM
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Share Price Tumble Recently, But Trouble May Still Be AfootAdaptive Biotechnologies Corporation (NASDAQ:ADPT) Share Price Tumble Recently, But Trouble May Still Be Afoot
stocksregister.com - April 17 at 1:54 PM
Insider Selling: Adaptive Biotechnologies Co. (NASDAQ:ADPT) Director Sells 4,500 Shares of StockInsider Selling: Adaptive Biotechnologies Co. (NASDAQ:ADPT) Director Sells 4,500 Shares of Stock
americanbankingnews.com - April 17 at 1:16 AM
MEDIA ALERT: KeyedIn to Host Adaptive PMO Virtual Event: Leveraging Artificial Intelligence for ...MEDIA ALERT: KeyedIn to Host Adaptive PMO Virtual Event: Leveraging Artificial Intelligence for ...
apnews.com - April 16 at 7:12 PM
Adaptive Web Hosting Announces Free SSL Certificates and Free DomainsAdaptive Web Hosting Announces Free SSL Certificates and Free Domains
pr.com - April 16 at 2:12 PM
Adaptive Biotechnologies (NASDAQ:ADPT) Trading 6.1% Higher Adaptive Biotechnologies (NASDAQ:ADPT) Trading 6.1% Higher
americanbankingnews.com - April 13 at 2:34 PM
Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021
finance.yahoo.com - April 12 at 6:47 PM
Dont Ignore The Fact That This Insider Just Sold Some Shares In Adaptive Biotechnologies Corporation (NASDAQ:ADPT)Don't Ignore The Fact That This Insider Just Sold Some Shares In Adaptive Biotechnologies Corporation (NASDAQ:ADPT)
nasdaq.com - April 11 at 1:46 PM
Press Release: ANA adopts Adaptive ACES mobile IFE solutionPress Release: ANA adopts Adaptive ACES mobile IFE solution
runwaygirlnetwork.com - April 10 at 1:33 PM
Hinkson Creek Collaborative Adaptive Management announces meetings for AprilHinkson Creek Collaborative Adaptive Management announces meetings for April
columbiamissourian.com - April 9 at 12:05 AM
Adaptive Biotechnologies Corp (ADPT) CFO Chad M Cohen Sold $826,000 of SharesAdaptive Biotechnologies Corp (ADPT) CFO Chad M Cohen Sold $826,000 of Shares
finance.yahoo.com - April 9 at 12:05 AM
Chad M. Cohen Sells 10,000 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) StockChad M. Cohen Sells 10,000 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) Stock
americanbankingnews.com - April 8 at 10:46 PM
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up to $40.63Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up to $40.63
americanbankingnews.com - April 8 at 10:44 AM
Critical Comparison: Novozymes A/S (OTCMKTS:NVZMY) versus Adaptive Biotechnologies (NASDAQ:ADPT)Critical Comparison: Novozymes A/S (OTCMKTS:NVZMY) versus Adaptive Biotechnologies (NASDAQ:ADPT)
americanbankingnews.com - April 7 at 12:10 AM
Challenged Athletes Foundation Launches Virtual High School Adaptive Sports ProgramChallenged Athletes Foundation Launches Virtual High School Adaptive Sports Program
apnews.com - April 6 at 5:38 PM
IEEE Industry Standards and Technology Organization Announces Formation of Adaptive ...IEEE Industry Standards and Technology Organization Announces Formation of Adaptive ...
apnews.com - April 6 at 12:37 PM
The College of Adaptive Arts opens new location at Saratogas West Valley CollegeThe College of Adaptive Arts opens new location at Saratoga's West Valley College
abc7news.com - April 6 at 12:44 AM
QAD Adaptive ERP 2021 launched for ManufacturersQAD Adaptive ERP 2021 launched for Manufacturers
enterprisetimes.co.uk - April 1 at 9:37 AM
Aqara rolling out Adaptive Lighting support to its HomeKit accessory lineupAqara rolling out Adaptive Lighting support to its HomeKit accessory lineup
9to5mac.com - April 1 at 12:58 AM
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 9.4%Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 9.4%
americanbankingnews.com - March 31 at 3:42 PM
Traders Buy High Volume of Adaptive Biotechnologies Call Options (NASDAQ:ADPT)Traders Buy High Volume of Adaptive Biotechnologies Call Options (NASDAQ:ADPT)
americanbankingnews.com - March 29 at 8:46 PM
Adaptive Biotechnologies Corp Enters Oversold TerritoryAdaptive Biotechnologies Corp Enters Oversold Territory
nasdaq.com - March 29 at 5:24 PM
DateCompanyBrokerageAction
1/25/2021Halozyme TherapeuticsBMO Capital MarketsBoost Price Target
1/21/2021Halozyme TherapeuticsBenchmarkBoost Price Target
1/14/2021Halozyme TherapeuticsPiper SandlerBoost Price Target
12/17/2020Halozyme TherapeuticsBerenberg BankInitiated Coverage
12/11/2020Halozyme TherapeuticsCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
12/11/2020Halozyme TherapeuticsSmith Barney CitigroupBoost Price Target
11/16/2020Halozyme TherapeuticsWells Fargo & CompanyBoost Price Target
9/14/2020Halozyme TherapeuticsJPMorgan Chase & Co.Initiated Coverage
5/19/2020Halozyme TherapeuticsCanaccord GenuityReiterated Rating
5/12/2020Halozyme TherapeuticsJMP SecuritiesBoost Price Target
5/4/2020Halozyme TherapeuticsCantor FitzgeraldBoost Price Target
2/25/2020Halozyme TherapeuticsBarclaysBoost Price Target
4/19/2021Kodiak SciencesMorgan StanleyLower Price Target
3/17/2021Kodiak SciencesEvercore ISIInitiated Coverage
2/17/2021Kodiak SciencesRoth CapitalDowngrade
12/15/2020Kodiak SciencesUBS GroupInitiated Coverage
11/13/2020Kodiak SciencesThe Goldman Sachs GroupDowngrade
7/28/2020Kodiak SciencesSunTrust BanksLower Price Target
2/5/2021Twist BioscienceRobert W. BairdBoost Price Target
11/24/2020Twist BioscienceSVB LeerinkBoost Price Target
7/8/2020Twist BioscienceCowenReiterated Rating
4/16/2021Vir BiotechnologyNeedham & Company LLCReiterated Rating
3/15/2021Vir BiotechnologyHC WainwrightBoost Price Target
10/5/2020Vir BiotechnologyBank of AmericaInitiated Coverage
1/19/2021Adaptive BiotechnologiesBTIG ResearchBoost Price Target
8/11/2020Adaptive BiotechnologiesWilliam BlairReiterated Rating
5/19/2020Adaptive BiotechnologiesGuggenheimBoost Price Target
(Data available from 4/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.